Table 3(a).
Term | HR | HR 95% lower | HR 95% upper | p Value |
---|---|---|---|---|
Former smoking versus never smoker | 0.901 | 0.582 | 1.396 | 0.641 |
Current smoking versus never smoker | 1.161 | 0.734 | 1.837 | 0.524 |
Age at diagnosis | 0.999 | 0.986 | 1.013 | 0.924 |
Male versus female | 0.809 | 0.509 | 1.287 | 0.371 |
NSAID use | 0.951 | 0.600 | 1.510 | 0.833 |
Aspirin use | 1.624 | 1.100 | 2.399 | 0.015 |
PPI use | 2.286 | 1.557 | 3.356 | <0.001 |
Statin use | 1.062 | 0.678 | 1.664 | 0.794 |
Histamine-2 antagonist use | 0.503 | 0.124 | 2.039 | 0.336 |
Antipsychotic medication use | 1.314 | 0.869 | 1.988 | 0.196 |
Budesonide treatment | 2.009 | 1.381 | 2.923 | <0.001 |
Prednisone treatment | 1.441 | 0.668 | 3.109 | 0.352 |
Imodium treatment | 0.812 | 0.558 | 1.180 | 0.274 |
Mesalamine treatment | 0.397 | 0.201 | 0.786 | 0.008 |
Bismuth treatment | 0.822 | 0.552 | 1.226 | 0.337 |
Other treatment options | 0.893 | 0.539 | 1.479 | 0.661 |
Presence of symptoms | 0.737 | 0.341 | 1.591 | 0.437 |
CC versus LC | 0.736 | 0.511 | 1.061 | 0.100 |
Index biopsies with mixed MC findings were not included in the analysis, and only assessments with a definitive diagnosis of CC or LC were considered as the index diagnosis. Mixed MC findings were only included if found after an index biopsy.
CC, collagenous colitis; HR, hazard ratio; LC, lymphocytic colitis; NSAID, nonsteroidal anti-inflammatory drugs; PPI, proton-pump inhibitor.